Getting your Trinity Audio player ready...
NEW YORK, Aug 31 (Reuters) – Medivation Inc :
* Shares were up 3.9 percent after resuming trade. Earlier in
the day, the FDA said a prostate cancer drug developed by
Medivation and Astellas Pharma Inc was approved by the
U.S. Food and Drug Administration for use in men whose cancer
has spread despite treatment with hormone therapy and
chemotherapy.
